Literature DB >> 16879572

Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma.

Petri Rekonen1, Tapio Kannisto, Tuomo Puustjärvi, Markku Teräsvirta, Hannu Uusitalo.   

Abstract

PURPOSE: To retrospectively compare the efficacy of deep sclerectomy in the treatment of primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG).
METHODS: Deep sclerectomy with either collagen or hyaluronate implants was performed in 31 eyes (45%) with POAG and 38 eyes (55%) with ExG. Pre- and postoperative intraocular pressure (IOP) was recorded, as was the number of glaucoma medications used pre- and postoperatively in each group. The follow-up data referred to a mean period of 18 months (range: 2 weeks to 36 months).
RESULTS: At 18 months, complete success had been achieved in 56.3% of POAG eyes and 44.9% of ExG eyes. Qualified success had been achieved in 83.1% and 71.6% of POAG and ExG eyes, respectively. The mean IOP was 18.6 mmHg in POAG eyes and 16.3 mmHg in ExG eyes. YAG-descemetotomies were performed in nine eyes in each group. There were no statistically significant differences between the groups in IOP (except at 1 week postoperatively in favour of POAG; p = 0.05), success rates, need for postoperative glaucoma medication or number of complications. Reoperations were required in three (10%) POAG eyes and seven (18%) ExG eyes.
CONCLUSIONS: Deep sclerectomy is equally effective in controlling IOP in both POAG and ExG and has low rates of serious complications, even when the surgeon is inexperienced in the technique. Both survival rates and IOP control were similar between the groups, and there were no serious intra- or postoperative complications.

Entities:  

Mesh:

Year:  2006        PMID: 16879572     DOI: 10.1111/j.1600-0420.2006.00654.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  6 in total

1.  Five-year results of non-penetrating deep sclerectomy with demineralized cancellous bone xenogenically derived collagen glaucoma implant.

Authors:  Natalia S Anisimova; Lisa B Arbisser; Sergey I Anisimov; Lusine L Arutyunyan; Natalya F Shilova; Gilyana Bashaeva; Roman V Kirtaev; Svetlana Yu Anisimova
Journal:  Int Ophthalmol       Date:  2021-03-03       Impact factor: 2.031

2.  Canaloplasty in Pseudoexfoliation Glaucoma. Can It Still Be Considered a Good Choice?

Authors:  Paolo Brusini; Veronica Papa; Marco Zeppieri
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

3.  Efficacy and safety of deep sclerectomy in uveitic glaucoma.

Authors:  Saleh A Al Obeidan; Essam A Osman; Abdulrahman M Al-Muammar; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2008-06-19       Impact factor: 2.031

Review 4.  Recent Advances in the Surgical Management of Glaucoma in Exfoliation Syndrome.

Authors:  Mohamed S Sayed; Richard K Lee
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

5.  Deep Sclerectomy with Nonabsorbable Implant (T-Flux) in Patients with Pseudoexfoliation Glaucoma.

Authors:  Pavel Studeny; Alina-Dana Baxant; Jana Vranova; Pavel Kuchynka; Jitka Pokorna
Journal:  J Ophthalmol       Date:  2017-01-15       Impact factor: 1.909

6.  Laser intervention on trabeculo-Descemet's membrane after resistant viscocanalostomy: Selective 532 nm gonioreconditioning or conventional 1064 nm neodymium-doped yttrium aluminum garnet laser goniopuncture?

Authors:  Huri Sabur; Mehmet Baykara; Basak Can
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.